Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

PubMed Links for Books (Select 1489426)

1.

Ocular changes in pregnancy.

Garg P, Aggarwal P.

Nepal J Ophthalmol. 2012 Jan-Jun;4(1):150-61. doi: 10.3126/nepjoph.v4i1.5867.

PMID:
22344013
2.

ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A.

Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Willett WC.

Arch Ophthalmol. 2012 Jun;130(6):707-11. doi: 10.1001/archophthalmol.2011.2580.

3.

A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement.

Bowne SJ, Humphries MM, Sullivan LS, Kenna PF, Tam LC, Kiang AS, Campbell M, Weinstock GM, Koboldt DC, Ding L, Fulton RS, Sodergren EJ, Allman D, Millington-Ward S, Palfi A, McKee A, Blanton SH, Slifer S, Konidari I, Farrar GJ, Daiger SP, Humphries P.

Eur J Hum Genet. 2011 Oct;19(10):1074-81. doi: 10.1038/ejhg.2011.86. Epub 2011 Jun 8. Erratum in: Eur J Hum Genet. 2011 Oct;19(10):1109.

4.

A missense mutation in PRPF6 causes impairment of pre-mRNA splicing and autosomal-dominant retinitis pigmentosa.

Tanackovic G, Ransijn A, Ayuso C, Harper S, Berson EL, Rivolta C.

Am J Hum Genet. 2011 May 13;88(5):643-9. doi: 10.1016/j.ajhg.2011.04.008. Epub 2011 May 5.

5.

Hereditary and clinical features of retinitis pigmentosa in Koreans.

Lee SH, Yu HG, Seo JM, Moon SW, Moon JW, Kim SJ, Chung H.

J Korean Med Sci. 2010 Jun;25(6):918-23. doi: 10.3346/jkms.2010.25.6.918. Epub 2010 May 24.

6.

How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa?

Massof RW, Fishman GA.

Arch Ophthalmol. 2010 Apr;128(4):493-5. doi: 10.1001/archophthalmol.2010.46. No abstract available.

PMID:
20385948
7.

Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A.

Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Brockhurst RJ, Hayes KC, Johnson EJ, Anderson EJ, Johnson CA, Gaudio AR, Willett WC, Schaefer EJ.

Arch Ophthalmol. 2010 Apr;128(4):403-11. doi: 10.1001/archophthalmol.2010.32.

8.

The molecular basis of human retinal and vitreoretinal diseases.

Berger W, Kloeckener-Gruissem B, Neidhardt J.

Prog Retin Eye Res. 2010 Sep;29(5):335-75. doi: 10.1016/j.preteyeres.2010.03.004. Epub 2010 Mar 31. Review.

PMID:
20362068
9.

Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait.

Wright AF, Chakarova CF, Abd El-Aziz MM, Bhattacharya SS.

Nat Rev Genet. 2010 Apr;11(4):273-84. doi: 10.1038/nrg2717. Review.

PMID:
20212494
10.

Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa.

Artunay O, Yuzbasioglu E, Rasier R, Sengul A, Bahcecioglu H.

J Ocul Pharmacol Ther. 2009 Dec;25(6):545-50. doi: 10.1089/jop.2009.0089.

PMID:
20028262
11.

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.

Maguire AM, High KA, Auricchio A, Wright JF, Pierce EA, Testa F, Mingozzi F, Bennicelli JL, Ying GS, Rossi S, Fulton A, Marshall KA, Banfi S, Chung DC, Morgan JI, Hauck B, Zelenaia O, Zhu X, Raffini L, Coppieters F, De Baere E, Shindler KS, Volpe NJ, Surace EM, Acerra C, Lyubarsky A, Redmond TM, Stone E, Sun J, McDonnell JW, Leroy BP, Simonelli F, Bennett J.

Lancet. 2009 Nov 7;374(9701):1597-605. doi: 10.1016/S0140-6736(09)61836-5. Epub 2009 Oct 23. Erratum in: Lancet. 2010 Jan 2;375(9708):30.

PMID:
19854499
12.

Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa.

Davidson AE, Millar ID, Urquhart JE, Burgess-Mullan R, Shweikh Y, Parry N, O'Sullivan J, Maher GJ, McKibbin M, Downes SM, Lotery AJ, Jacobson SG, Brown PD, Black GC, Manson FD.

Am J Hum Genet. 2009 Nov;85(5):581-92. doi: 10.1016/j.ajhg.2009.09.015. Epub 2009 Oct 22.

13.

Unilateral retinitis pigmentosa and cone-rod dystrophy.

Farrell DF.

Clin Ophthalmol. 2009;3:263-70. Epub 2009 Jun 2.

14.

Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa.

Yuzbasioglu E, Artunay O, Rasier R, Sengul A, Bahcecioglu H.

Curr Eye Res. 2009 Mar;34(3):231-7. doi: 10.1080/02713680802710692.

PMID:
19274531
15.

Intraocular epiretinal prosthesis to restore vision in blind humans.

Mokwa W, Goertz M, Koch C, Krisch I, Trieu HK, Walter P.

Conf Proc IEEE Eng Med Biol Soc. 2008;2008:5790-3. doi: 10.1109/IEMBS.2008.4650530.

PMID:
19164033
16.

Ophthalmological abnormalities in children with congenital disorders of glycosylation type I.

Morava E, Wosik HN, Sykut-Cegielska J, Adamowicz M, Guillard M, Wevers RA, Lefeber DJ, Cruysberg JR.

Br J Ophthalmol. 2009 Mar;93(3):350-4. doi: 10.1136/bjo.2008.145359. Epub 2008 Nov 19.

PMID:
19019927
17.

Thickness of receptor and post-receptor retinal layers in patients with retinitis pigmentosa measured with frequency-domain optical coherence tomography.

Hood DC, Lin CE, Lazow MA, Locke KG, Zhang X, Birch DG.

Invest Ophthalmol Vis Sci. 2009 May;50(5):2328-36. doi: 10.1167/iovs.08-2936. Epub 2008 Nov 14.

18.

Adaptive optics scanning laser ophthalmoscopy images in a family with the mitochondrial DNA T8993C mutation.

Yoon MK, Roorda A, Zhang Y, Nakanishi C, Wong LJ, Zhang Q, Gillum L, Green A, Duncan JL.

Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1838-47. doi: 10.1167/iovs.08-2029. Epub 2008 Nov 7.

PMID:
18997096
19.

NT-501: an ophthalmic implant of polymer-encapsulated ciliary neurotrophic factor-producing cells.

Emerich DF, Thanos CG.

Curr Opin Mol Ther. 2008 Oct;10(5):506-15. Review.

PMID:
18830926
20.

Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.

Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L, Conlon TJ, Boye SL, Flotte TR, Byrne BJ, Jacobson SG.

Hum Gene Ther. 2008 Oct;19(10):979-90. doi: 10.1089/hum.2008.107.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk